These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2273204)

  • 21. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
    J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of calcitonin in the development and treatment of osteoporosis.
    McDermott MT; Kidd GS
    Endocr Rev; 1987 Nov; 8(4):377-90. PubMed ID: 3319529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis and management of primary osteoporosis.
    Bauwens SF; Drinka PJ; Boh LE
    Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes of calcitonin reserve function in patients with primary osteoporosis].
    Zhan Z; Meng X; Zhou X
    Zhonghua Nei Ke Za Zhi; 1997; 36(1):11-4. PubMed ID: 9812553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis?
    Taggart HM; Chesnut CH; Ivey JL; Baylink DJ; Sisom K; Huber MB; Roos BA
    Lancet; 1982 Feb; 1(8270):475-8. PubMed ID: 6121141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased calcitonin reserve in accelerated postmenopausal osteoporosis.
    Zséli J; Szücs J; Steczek K; Szathmári M; Kollin E; Horváth C; Guoth M; Holló I
    Horm Metab Res; 1985 Dec; 17(12):696-7. PubMed ID: 4085976
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in bone mineral content and bone metabolism related to menopause].
    Ohta H; Nemoto K; Nozawa S; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1447-54. PubMed ID: 2584821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Wensel TM; Iranikhah MM; Wilborn TW
    Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menopausal bone loss and estrogen replacement.
    Meema S; Meema HE
    Isr J Med Sci; 1976 Jul; 12(7):601-6. PubMed ID: 972014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen treatment of patients with established postmenopausal osteoporosis.
    Lindsay R; Tohme JF
    Obstet Gynecol; 1990 Aug; 76(2):290-5. PubMed ID: 2371033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.
    Aloia JF; Vaswani A; Meunier PJ; Edouard CM; Arlot ME; Yeh JK; Cohn SH
    Calcif Tissue Int; 1987 May; 40(5):253-9. PubMed ID: 2981045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen and bone. Marshall R. Urist's contributions.
    Gordan GS
    Clin Orthop Relat Res; 1985 Nov; (200):174-80. PubMed ID: 3905109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of estrogen (Premarin) replacement therapy on serum level of total estrogen and urinary excretion of calcium and hydroxyproline in postmenopausal Chinese women.
    Ouyang PC; Chow SN; Huang SC; Hsieh CY
    Proc Natl Sci Counc Repub China B; 1986 Jul; 10(3):162-6. PubMed ID: 3022320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New approaches to the problems of osteoporosis.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Clin Orthop Relat Res; 1985 Nov; (200):181-97. PubMed ID: 3905110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of estradiol and progesterone on calcitonin secretion.
    Greenberg C; Kukreja SC; Bowser EN; Hargis GK; Henderson WJ; Williams GA
    Endocrinology; 1986 Jun; 118(6):2594-8. PubMed ID: 3698924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapy.
    Fogelman I; Fordham JN; Fraser WD; Spector TD; Christiansen C; Morris SA; Fox J
    Calcif Tissue Int; 2008 Aug; 83(2):85-92. PubMed ID: 18626566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of intravenous calcium load on serum calcitonin levels in postmenopausal osteoporotic women].
    Zséli J; Szücs J; Steczek K; Szathmári M; Kollin E; Horváth C; Guoth M; Holló I
    Orv Hetil; 1985 Mar; 126(13):771-3. PubMed ID: 3991169
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.